09-02-2022, 06:02 PM
In short, its serum has won 70% market share in the United States and the European Union , said its CEO, Albert Bourla. Turnover thus jumped by 95%, to 81.3 billion dollars. Its net profit more than doubled to $22 billion. "2021 has been a pivotal year for Pfizer", commented Albert Bourla, in a message published on the occasion of the publication of the results.
Pfizer does six more than Moderna and BioNTech in 2021
Thus, in total, the strong demand for products linked to the pandemic should allow it to reach for the first time around 100 billion dollars in turnover in 2022, against an 81.3 billion dollars in 2021 (already up 95%).
For the fourth quarter of 2021 alone, the group's turnover more than doubled to 23.8 billion dollars. But without sales of the vaccine ($12.5 billion) and anti-Covid treatment, it fell 2%.
Its Comirnaty vaccine with BioNTech alone grossed $36.8 billion in total in 2021.
By way of comparison, its partner BioNTech forecasts a turnover of between 16 and 17 billion dollars in 2021, while it generated only a few tens of millions two years earlier. Similarly, Moderna is counting on 15 to 18 billion in revenue, a thousand times more than in 2019. For its part, Sanofi the French laboratory - in failure on anti-Covid vaccines - recorded a turnover of nearly of 37.8 billion euros in 2021, up 4.8%.
https://www.latribune.fr/entreprises-fin...03656.html
Pfizer does six more than Moderna and BioNTech in 2021
Thus, in total, the strong demand for products linked to the pandemic should allow it to reach for the first time around 100 billion dollars in turnover in 2022, against an 81.3 billion dollars in 2021 (already up 95%).
For the fourth quarter of 2021 alone, the group's turnover more than doubled to 23.8 billion dollars. But without sales of the vaccine ($12.5 billion) and anti-Covid treatment, it fell 2%.
Its Comirnaty vaccine with BioNTech alone grossed $36.8 billion in total in 2021.
By way of comparison, its partner BioNTech forecasts a turnover of between 16 and 17 billion dollars in 2021, while it generated only a few tens of millions two years earlier. Similarly, Moderna is counting on 15 to 18 billion in revenue, a thousand times more than in 2019. For its part, Sanofi the French laboratory - in failure on anti-Covid vaccines - recorded a turnover of nearly of 37.8 billion euros in 2021, up 4.8%.
https://www.latribune.fr/entreprises-fin...03656.html
![[Image: MaleTenderKillerwhale-size_restricted.gif]](https://thumbs.gfycat.com/MaleTenderKillerwhale-size_restricted.gif)